SCHEMBL7398430

SCHEMBL7398430

CCCCc1nn(CCCCC(=O)O)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ AGTR1 P30556 16/20 0.74
▸ AGTR2 P50052 16/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7398978 0.92 AGTR1 (0.71) AGTR1AGTR2
SCHEMBL7398754 0.92 AGTR1 (0.72) AGTR1AGTR2
SCHEMBL7828850 0.92 AGTR1 (0.72) AGTR1AGTR2
SCHEMBL7828364 0.92 AGTR1 (0.72) AGTR1AGTR2
SCHEMBL7398914 0.92 AGTR1 (0.71) AGTR1AGTR2
SCHEMBL7396576 0.91 AGTR1 (0.75) AGTR1AGTR2
SCHEMBL7398483 0.91 AGTR1 (0.72) AGTR1AGTR2
SCHEMBL7818972 0.91 AGTR1 (0.69) AGTR1AGTR2
SCHEMBL7399866 0.90 AGTR1 (0.73) AGTR1AGTR2
SCHEMBL9032389 0.90 AGTR1 (0.64) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0531382-A1 N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-03-17 — — EP claimed
WO-1991018888-A1 N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-12-12 — — WO claimed
EP-0531382-A1 N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-03-17 — — EP disclosed
WO-1991018888-A1 N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-12-12 — — WO disclosed
Send feedback